These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

55 related items for PubMed ID: 9162139

  • 1. Redesigning the substrate specificity of the hepatitis C virus NS3 protease.
    Failla CM, Pizzi E, Francesco RD, Tramontano A.
    Fold Des; 1995; 1(1):35-42. PubMed ID: 9162139
    [Abstract] [Full Text] [Related]

  • 2. Redesigning the substrate specificity of the hepatitis C virus NS3 protease.
    Failla CM, Pizzi E, De Francesco R, Tramontano A.
    Fold Des; 1996; 1(1):35-42. PubMed ID: 9079362
    [Abstract] [Full Text] [Related]

  • 3. The hepatitis C virus NS3 proteinase: structure and function of a zinc-containing serine proteinase.
    De Francesco R, Pessi A, Steinkühler C.
    Antivir Ther; 1998; 3(Suppl 3):99-109. PubMed ID: 10726060
    [Abstract] [Full Text] [Related]

  • 4. Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping.
    Landro JA, Raybuck SA, Luong YP, O'Malley ET, Harbeson SL, Morgenstern KA, Rao G, Livingston DJ.
    Biochemistry; 1997 Aug 05; 36(31):9340-8. PubMed ID: 9235976
    [Abstract] [Full Text] [Related]

  • 5. NS3 serine protease of bovine viral diarrhea virus: characterization of active site residues, NS4A cofactor domain, and protease-cofactor interactions.
    Tautz N, Kaiser A, Thiel HJ.
    Virology; 2000 Aug 01; 273(2):351-63. PubMed ID: 10915606
    [Abstract] [Full Text] [Related]

  • 6. Product inhibition of the hepatitis C virus NS3 protease.
    Steinkühler C, Biasiol G, Brunetti M, Urbani A, Koch U, Cortese R, Pessi A, De Francesco R.
    Biochemistry; 1998 Jun 23; 37(25):8899-905. PubMed ID: 9636031
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage products.
    Ingallinella P, Altamura S, Bianchi E, Taliani M, Ingenito R, Cortese R, De Francesco R, Steinkühler C, Pessi A.
    Biochemistry; 1998 Jun 23; 37(25):8906-14. PubMed ID: 9636032
    [Abstract] [Full Text] [Related]

  • 9. A high-throughput radiometric assay for hepatitis C virus NS3 protease.
    Cerretani M, Di Renzo L, Serafini S, Vitelli A, Gennari N, Bianchi E, Pessi A, Urbani A, Colloca S, De Francesco R, Steinkühler C, Altamura S.
    Anal Biochem; 1999 Jan 15; 266(2):192-7. PubMed ID: 9888975
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Solution structure and dynamics of the single-chain hepatitis C virus NS3 protease NS4A cofactor complex.
    McCoy MA, Senior MM, Gesell JJ, Ramanathan L, Wyss DF.
    J Mol Biol; 2001 Feb 02; 305(5):1099-110. PubMed ID: 11162117
    [Abstract] [Full Text] [Related]

  • 12. Serine protease of hepatitis C virus expressed in insect cells as the NS3/4A complex.
    Sali DL, Ingram R, Wendel M, Gupta D, McNemar C, Tsarbopoulos A, Chen JW, Hong Z, Chase R, Risano C, Zhang R, Yao N, Kwong AD, Ramanathan L, Le HV, Weber PC.
    Biochemistry; 1998 Mar 10; 37(10):3392-401. PubMed ID: 9521660
    [Abstract] [Full Text] [Related]

  • 13. An uniquely purified HCV NS3 protease and NS4A(21-34) peptide form a highly active serine protease complex in peptide hydrolysis.
    Sardana VV, Blue JT, Zugay-Murphy J, Sardana MK, Kuo LC.
    Protein Expr Purif; 1999 Aug 10; 16(3):440-7. PubMed ID: 10425166
    [Abstract] [Full Text] [Related]

  • 14. Enzymatic characterization of membrane-associated hepatitis C virus NS3-4A heterocomplex serine protease activity expressed in human cells.
    Hamill P, Jean F.
    Biochemistry; 2005 May 03; 44(17):6586-96. PubMed ID: 15850392
    [Abstract] [Full Text] [Related]

  • 15. Molecular virology of hepatitis C virus: an update with respect to potential antiviral targets.
    Blight KJ, Kolykhalov AA, Reed KE, Agapov EV, Rice CM.
    Antivir Ther; 1998 May 03; 3(Suppl 3):71-81. PubMed ID: 10726057
    [Abstract] [Full Text] [Related]

  • 16. The design of a potent inhibitor of the hepatitis C virus NS3 protease: BILN 2061--from the NMR tube to the clinic.
    Tsantrizos YS.
    Biopolymers; 2004 May 03; 76(4):309-23. PubMed ID: 15386268
    [Abstract] [Full Text] [Related]

  • 17. Determinants of substrate specificity in the NS3 serine proteinase of the hepatitis C virus.
    Koch JO, Bartenschlager R.
    Virology; 1997 Oct 13; 237(1):78-88. PubMed ID: 9344909
    [Abstract] [Full Text] [Related]

  • 18. Modified apoptotic molecule (BID) reduces hepatitis C virus infection in mice with chimeric human livers.
    Hsu EC, Hsi B, Hirota-Tsuchihara M, Ruland J, Iorio C, Sarangi F, Diao J, Migliaccio G, Tyrrell DL, Kneteman N, Richardson CD.
    Nat Biotechnol; 2003 May 13; 21(5):519-25. PubMed ID: 12704395
    [Abstract] [Full Text] [Related]

  • 19. Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A.
    Thibeault D, Massariol MJ, Zhao S, Welchner E, Goudreau N, Gingras R, Llinàs-Brunet M, White PW.
    Biochemistry; 2009 Feb 03; 48(4):744-53. PubMed ID: 19119853
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of the bovine viral diarrhoea virus NS3 serine protease by a boron-modified peptidyl mimetic of its natural substrate.
    Bukhtiyarova M, Rizzo CJ, Kettner CA, Korant BD, Scarnati HT, King RW.
    Antivir Chem Chemother; 2001 Nov 03; 12(6):367-73. PubMed ID: 12018682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.